[go: up one dir, main page]

CO4750837A1 - BORONIC ACID DERIVATIVES - Google Patents

BORONIC ACID DERIVATIVES

Info

Publication number
CO4750837A1
CO4750837A1 CO96039770A CO96039770A CO4750837A1 CO 4750837 A1 CO4750837 A1 CO 4750837A1 CO 96039770 A CO96039770 A CO 96039770A CO 96039770 A CO96039770 A CO 96039770A CO 4750837 A1 CO4750837 A1 CO 4750837A1
Authority
CO
Colombia
Prior art keywords
acid derivatives
boronic acid
formula
residue
compound
Prior art date
Application number
CO96039770A
Other languages
Spanish (es)
Inventor
Anette Wienand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CO4750837A1 publication Critical patent/CO4750837A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula I:caracterizado porque cada uno de Q1 y Q2 es OH o Q1 y Q2 forman conjuntamente un residuo de la fórmula (a)en la forma libre o, cuando cada uno de Q1 y Q2 es OH, también en la forma de sal.A compound of formula I: characterized in that each of Q1 and Q2 is OH or Q1 and Q2 together form a residue of formula (a) in the free form or, when each of Q1 and Q2 is OH, also in the salt form.

CO96039770A 1995-07-28 1996-07-26 BORONIC ACID DERIVATIVES CO4750837A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9515489.4A GB9515489D0 (en) 1995-07-28 1995-07-28 Organic compounds

Publications (1)

Publication Number Publication Date
CO4750837A1 true CO4750837A1 (en) 1999-03-31

Family

ID=10778404

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96039770A CO4750837A1 (en) 1995-07-28 1996-07-26 BORONIC ACID DERIVATIVES

Country Status (5)

Country Link
AU (1) AU6737996A (en)
CO (1) CO4750837A1 (en)
GB (1) GB9515489D0 (en)
WO (1) WO1997005161A1 (en)
ZA (1) ZA966396B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
KR20030080810A (en) * 2002-04-11 2003-10-17 주식회사 엘지생명과학 Selective thrombin inhibitors with an aminopyridoaryl group
JP2006511593A (en) 2002-09-09 2006-04-06 トライジェン・リミテッド Boronate and its use in the treatment of thrombosis
US7371729B2 (en) 2002-09-09 2008-05-13 Trigen Limited Boronic acid salts useful in parenteral formulations
EP2982668A3 (en) 2002-12-03 2016-04-13 Pharmacyclics LLC 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
MY131622A (en) * 1993-03-03 2007-08-30 Novartis Ag Organic compounds
GB9401483D0 (en) * 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ZA966396B (en) 1998-01-26
AU6737996A (en) 1997-02-26
GB9515489D0 (en) 1995-09-27
WO1997005161A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
AR038429A2 (en) MARCFORTINA 15-RENT-16-HYDROXYL COMPOUNDS
DE69223833D1 (en) Use of a grease composition for homokinetic coupling
DE69132374D1 (en) Connector for office wall panels
DE3582626D1 (en) SILICA-TITANIA-COGEL THROUGH TWO-STAGE HYDROLYSIS.
HU9500245D0 (en) Injection and injection kit containing omeprazole and its analogs
ATE86668T1 (en) DIABETIC COMPOUNDS.
KR910000883U (en) Fuel supply pipe
DE3460577D1 (en) Sodium salt of ursodeoxycholic sulphate
DE59106598D1 (en) HIGHLY CONCENTRATED PASTE OF ALPHA SULFOURIC ACID ALKYL ALKALINE METAL SALTS.
ES8700666A1 (en) 2-(Pyridylalkylenesulfinyl) benzimidazoles.
TR199902283T2 (en) Substituted isoquinoline derivatives and their use as anticonvulsants.
TR200000786T2 (en) Vitronectin receptor antagonist
ES483901A1 (en) Cephem compounds
CO4750837A1 (en) BORONIC ACID DERIVATIVES
FR2531737B1 (en) PANEL CONSTRUCTION, PARTICULARLY FOR THE FITTING OF A STABLE STABLE FOR HORSES
ATE87662T1 (en) DIABETIC COMPOUNDS.
AU3472384A (en) Corrosion inhibitors
DK0589322T3 (en) 5-Oxo-dibenzo a, d cyclohepta-1,4-dienes as well as their use as retroviral agents.
CO4650017A1 (en) OXAZOLINE ARTROPODICIDES
NO913798D0 (en) PROCEDURE FOR THE PROMOTION OF CALCIUM CARBONATE DEPOSITION IN Aqueous Systems.
HK1016971A1 (en) Production of a salt of clavulanic acid
IT8420775V0 (en) MUSICAL BODY, AS WELL AS LIGHTING, AUTOMATIC.
RO84457B (en) Process for preparing 7-beta-aminooxazolylacetylamino-3-cephem-4-carboxylic acid derivatives
YU43499A (en) Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acid
EP0352013A3 (en) Hydroxymethyl cyclobutyl purines